Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-10 Sale | 2022-05-12 8:45 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 2,200 | $21.51 | $47,322 | 35,655 (Direct) | View |
| 2022-02-23 Sale | 2022-02-24 1:54 pm | Genasys Inc. | GNSS | Clague Laura Director | 13,716 | $3.14 | $43,068 | 206,311 (Indirect Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:17 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 1,238 | $27.4 | $33,921 | 95,055 (Direct) | View |
| 2022-01-24 Sale | 2022-01-26 4:34 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 2,063 | $24.98 | $51,534 | 29,253 (Direct) | View |
| 2022-01-11 Sale | 2022-01-12 4:05 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 7,500 | $27.4 | $205,500 | 31,316 (Direct) | View |
| 2021-08-17 Sale | 2021-08-17 7:34 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 1,407 | $17.12 | $24,085 | 31,316 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 4:07 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 4,000 | $19.3 | $77,200 | 28,223 (Direct) | View |
| 2021-03-10 Sale | 2021-03-12 12:43 pm | Genasys Inc. | GNSS | Clague Laura Director | 5,456 | $7.4166 | $40,465 | 170,144 (Direct) | View |
| 2021-02-05 Sale | 2021-02-09 4:29 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 4,500 | $31.5 | $141,728 | 32,223 (Direct) | View |
| 2021-02-03 Sale | 2021-02-03 9:30 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 3,625 | $28.91 | $104,799 | 32,223 (Direct) | View |
| 2021-02-02 Sale | 2021-02-02 9:19 pm | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 3,625 | $30.75 | $111,469 | 35,848 (Direct) | View |
| 2020-11-24 Sale | 2020-11-25 7:00 pm | Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer | 7,500 | $23.29 | $174,675 | 19,473 (Direct) | View |
| 2020-11-16 Sale | 2020-11-17 9:00 pm | Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer | 7,500 | $23.98 | $179,813 | 19,473 (Direct) | View |
| 2020-11-13 Sale | 2020-11-13 9:24 pm | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 7,500 | $23.61 | $177,071 | 26,973 (Direct) | View |
| 2020-09-23 Sale | 2020-09-23 8:00 pm | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 1,500 | $18.48 | $27,720 | 19,473 (Direct) | View |
| 2020-09-22 Sale | 2020-09-22 9:18 pm | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 1,500 | $18.59 | $27,885 | 20,973 (Direct) | View |
| 2020-05-11 Sale | 2020-05-13 9:00 pm | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 3,027 | $16.22 | $49,088 | 19,473 (Direct) | View |
| 2020-03-10 Sale | 2020-03-12 7:43 pm | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 4,000 | $15.02 | $60,080 | 22,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-14 Option Award | 2023-06-16 8:41 pm | N/A 2033-06-14 | STANDARD BIOTOOLS INC. | LAB | Clague Laura Director | 61,756 | $0 | 140,171 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 6:04 pm | N/A 2032-06-15 | STANDARD BIOTOOLS INC. | LAB | Clague Laura Director | 73,485 | $0 | 120,986 (Direct) | View |
| 2022-04-27 Exercise | 2022-04-27 7:02 pm | 2014-05-10 2022-05-10 | Genasys Inc. | GNSS | Clague Laura Director | 50,000 | $0 | 286,311 (Direct) | View |
| 2022-04-27 Exercise | 2022-04-27 7:02 pm | N/A N/A | Genasys Inc. | GNSS | Clague Laura Director | 50,000 | $1.33 | 286,311 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 3:36 pm | N/A N/A | Genasys Inc. | GNSS | Clague Laura Director | 30,000 | $0 | 236,311 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-24 1:54 pm | 2016-03-18 2022-03-18 | Genasys Inc. | GNSS | Clague Laura Director | 20,000 | $0 | 206,311 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-24 1:54 pm | N/A N/A | Genasys Inc. | GNSS | Clague Laura Director | 20,000 | $2.16 | 206,311 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:17 pm | N/A 2032-01-30 | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 67,040 | $0 | 95,055 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 7,500 | $0 | 31,316 (Direct) | View |
| 2021-08-13 Option Award | 2021-08-17 7:34 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 4,500 | $0 | 31,316 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 5:28 pm | N/A 2031-05-25 | FLUIDIGM CORP | FLDM | Clague Laura Director | 25,744 | $0 | 62,903 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 4:52 pm | N/A N/A | Genasys Inc. | GNSS | Clague Laura Director | 27,883 | $0 | 168,027 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 12:43 pm | 2015-03-26 2021-03-26 | Genasys Inc. | GNSS | Clague Laura Director | 20,000 | $0 | 170,144 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 12:43 pm | N/A N/A | Genasys Inc. | GNSS | Clague Laura Director | 20,000 | $2.02 | 170,144 (Direct) | View |
| 2021-02-20 Option Award | 2021-02-23 9:58 pm | N/A N/A | FLUIDIGM CORP | FLDM | Clague Laura Director | 9,803 | $0 | 37,159 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:46 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 4,500 | $0 | 36,723 (Direct) | View |
| 2021-01-31 Option Award | 2021-02-02 9:19 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 5,000 | $0 | 35,848 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 8:55 pm | N/A 2031-01-20 | Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer | 72,500 | $0 | 91,973 (Direct) | View |
| 2020-11-23 Option Award | 2020-11-25 7:00 pm | N/A N/A | Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer | 7,500 | $0 | 19,473 (Direct) | View |
| 2020-11-11 Option Award | 2020-11-13 9:24 pm | N/A N/A | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 15,000 | $0 | 26,973 (Direct) | View |
| 2020-09-18 Option Award | 2020-09-22 9:18 pm | N/A N/A | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 3,000 | $0 | 20,973 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 3:59 pm | N/A 2030-06-23 | FLUIDIGM CORP | FLDM | Clague Laura Director | 34,362 | $0 | 48,349 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 6:49 pm | N/A N/A | Genasys Inc. | LRAD | Clague Laura Director | 30,000 | $0 | 155,600 (Direct) | View |
| 2020-03-12 Exercise | 2020-03-12 6:49 pm | N/A N/A | Genasys Inc. | LRAD | Clague Laura Director | 30,000 | $0 | 155,600 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-09 9:06 pm | N/A N/A | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 4,000 | $0 | 26,500 (Direct) | View |
| 2020-01-31 Option Award | 2020-01-31 8:15 pm | N/A 2030-01-30 | Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer | 74,000 | $0 | 96,500 (Direct) | View |